These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34882803)

  • 1. Growth hormone treatment does not to lead to insulin resistance nor excessive rise in IGF-1 levels, while improving height in patients small for gestational age A long-term observational study.
    López-Siguero JP; Martínez-Aedo MJ; Bermúdez de la Vega JA; Bosch-Muñoz J; Lechuga-Sancho AM; Villalobos T;
    Clin Endocrinol (Oxf); 2022 Apr; 96(4):558-568. PubMed ID: 34882803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short children with low birth weight born either small for gestational age or average for gestational age show similar growth response and changes in insulin-like growth factor-1 to growth hormone treatment during the first prepubertal year.
    Ranke MB; Martin DD; Ehehalt S; Schwarze CP; Serra F; Wollmann HA; Schweizer R
    Horm Res Paediatr; 2011; 76(2):104-12. PubMed ID: 21757866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis.
    Cutfield WS; Lindberg A; Rapaport R; Wajnrajch MP; Saenger P
    Horm Res; 2006; 65 Suppl 3():153-9. PubMed ID: 16612129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate and the response to growth hormone treatment in short children born small for gestational age.
    Renes JS; de Ridder MA; Breukhoven PE; Lem AJ; Hokken-Koelega AC
    PLoS One; 2012; 7(12):e53164. PubMed ID: 23300884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
    Garcia RA; Longui CA; Kochi C; Arruda M; Faria CD; Calliari LE; Monte O; Pachi PR; Saenger P
    Horm Res; 2009; 72(5):275-80. PubMed ID: 19844113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment.
    Hokken-Koelega AC; De Waal WJ; Sas TC; Van Pareren Y; Arends NJ
    J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():463-9. PubMed ID: 15134308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
    de Ridder MA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
    Arends NJ; Boonstra VH; Hokken-Koelega AC
    Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic impact of growth hormone treatment in short children born small for gestational age.
    Lebl J; Lebenthal Y; Kolouskova S; Steensberg A; Jøns K; Kappelgaard AM; Ibáñez L; Phillip M
    Horm Res Paediatr; 2011; 76(4):254-61. PubMed ID: 21893941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
    Labarta JI; de Arriba A; Ferrer M; Loranca M; Martos JM; Rodríguez A; Samaniego ML; Sánchez-Cenizo L
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):923-932. PubMed ID: 32623373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children born small-for-gestational age: postnatal growth and hormonal status.
    Albertsson-Wikland K; Boguszewski M; Karlberg J
    Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seventy eight children born small for gestational age without catch-up growth treated with growth hormone from the prepubertal stage until adult height age. An evaluation of puberty and changes in the metabolic profile.
    Campos-Martorell A; Fernández-Cancio M; Clemente León M; Mogas Viñals E; Fàbregas Martori A; Carrascosa Lezcano A; Yeste Fernández D
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Nov; 68(9):612-620. PubMed ID: 34906341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline IGF-I levels determine insulin secretion and insulin sensitivity during the first year on growth hormone therapy in children born small for gestational age. Results from a North European Multicentre Study (NESGAS).
    Jensen RB; Thankamony A; O'Connell SM; Salgin B; Kirk J; Donaldson M; Ivarsson SA; Söder O; Roche E; Hoey H; Dunger DB; Juul A;
    Horm Res Paediatr; 2013; 80(1):38-46. PubMed ID: 23860366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in Bioactive IGF do not Parallel Increases in Total IGF-I During Growth Hormone Treatment of Children Born SGA.
    Wegmann MG; Jensen RB; Thankamony A; Frystyk J; Roche E; Hoey H; Kirk J; Shaikh G; Ivarsson SA; Söder O; Dunger DB; Juul A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31665326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.